Feasibility Study of Unfractionated Heparin in Acute Chest Syndrome
Unfractionated Heparin in Acute Chest Syndrome: A Pilot Feasibility Randomized Controlled Trial of Unfractionated Heparin vs. Standard of Care in Acute Chest Syndrome
Sponsor: Craig Seaman
Terminated
Poor enrollment.
Other terminated trials from Craig Seaman
More terminations from Craig Seaman
Other Acute Chest Syndrome trials with similar outcome
A PHASE2 clinical study on Acute Chest Syndrome and Sickle Cell Disease, this trial is terminated or withdrawn. The trial is conducted by Craig Seaman and has accumulated 10 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE2
-
Jan 2021 — Dec 2022 [monthly]
Terminated PHASE2
▶ Show 5 earlier versions
-
Aug 2019 — Jan 2021 [monthly]
Terminated PHASE2
-
Jul 2018 — Aug 2019 [monthly]
Terminated PHASE2
Status: Recruiting → Terminated
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
May 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Craig Seaman
- Vascular Medicine Institute
For direct contact, visit the study record on ClinicalTrials.gov .